Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

GSK takes stake in biotech spin-out

October 5, 2010 Research and Development, Sales and Marketing Convergence, GlaxoSmithKline, funding

GlaxoSmithKline has taken a stake in a newly-launched biotech company in return for handing it two clinical compounds. The pharma …
News

Svend Andersen to lead Hospira in Europe

October 5, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Hospira, appointment, manufacturing and production, research and development, sales and marketing

US global specialty pharmaceutical company Hospira has appointed Svend Andersen to lead its operations in Europe with effect from 1 …
Appointment

Talking R&D: Evolving technical standards

October 5, 2010 Manufacturing and Production, Research and Development Talking R&D, eCTD, eCTD submissions

The European Union (EU) Module 1 specification works in parallel with the ICH eCTD Specification. It was first introduced in …
Feature

Sanofi makes hostile offer for Genzyme

October 4, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis’ courtship dance around Genzyme has turned more aggressive with an offer – made over the heads of Genzyme’s board …
News

GSK drops herpes vaccine

October 4, 2010 Research and Development, Sales and Marketing GlaxoSmithKline, Simplirix, herpes, sexual health

Poor phase III results have forced GlaxoSmithKline to halt development of its Simplirix vaccine for women with genital herpes. The …
News

Talking R&D: US regulatory guidelines

October 4, 2010 Manufacturing and Production, Research and Development Talking R&D, eCTD submissions

Recent speculation surrounding current diabetes drugs and their long term effect on cardiovascular health has heads spinning in the pharmaceutical …
Feature

AZ-BMS diabetes drug impresses in phase III trials

October 1, 2010 Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes

AstraZeneca and Bristol Myers Squibb’s potential first-in-class diabetes drug dapagliflozin has shown strong results in a late stage trial. It …
News

FDA unveils new trial data rules

October 1, 2010 Research and Development FDA, clinical trials, pharmacovigilance

The FDA has clarified its rules on what safety information must be reported during clinical trials of investigational drugs and …
News

BMS poaches AZ’s head of global medical affairs

October 1, 2010 Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Dr Rick Lones as executive medical director in the UK. He joins BMS from AstraZeneca, where …
Appointment

Sanofi signs $2.2bn CRO deal

October 1, 2010 Research and Development CRO, Covance, Sanofi-Aventis

Sanofi-Aventis has signed a major deal to contract out a wide range of drug development and laboratory services as part …
News

Contract research news in brief

September 29, 2010 Research and Development CIT, Cardialysis, PPD, Parexel, Porsolt, Sticares

A round-up of recent news from the CRO sector, featuring updates from CIT, Parexel, PPD, Cardialysis/Sticares and Porsolt. French non-clinical …
News

ClinTec recruits former Wyeth VP

September 29, 2010 Research and Development ClinTec, appointment, research and development

Glasgow, UK-based contract research organisation ClinTec has expanded its US operations with the appointment of new executive vice president Dr …
Appointment
FDA director of manufacturing and product quality Rich Friedman

The FDA Interview: Is pharma getting worse at manufacturing?

September 29, 2010 Manufacturing and Production, Research and Development FDA, manufacturing, manufacturing compliance

It seems that barely a week goes by at the moment without news of another pharmaceutical company falling foul of …
Feature

Pfizer slims down pipeline

September 28, 2010 Research and Development Pfizer

Pfizer has reduced the number of drugs in its product pipeline as part of a broad refocusing of its R&D …
News

European Commission eyes pharma ethics

September 27, 2010 Research and Development, Sales and Marketing European Commission, corporate responsibility, ethics

The European Commission is to examine corporate responsibility in the pharmaceutical industry with the aim of developing a series of …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026